- call +1-201-465-4211
- email sales@mrinsights.biz
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Scope of the Report:
Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.
The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 USD/Unit in 2012 to 34.9 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.
Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.
North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.
North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%.
Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)
Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Testosterone Replacement Therapy is expected to grow at a CAGR of roughly -4.2% over the next five years, will reach 1410 million US$ in 2024, from 1820 million US$ in 2019, according to a new study.
This report focuses on the Testosterone Replacement Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Gels
Injections
Patches
Other
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Testosterone Replacement Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Testosterone Replacement Therapy, with price, sales, revenue and global market share of Testosterone Replacement Therapy in 2017 and 2018.
Chapter 3, the Testosterone Replacement Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Testosterone Replacement Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Testosterone Replacement Therapy market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Testosterone Replacement Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Testosterone Replacement Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Gels
1.2.2 Injections
1.2.3 Patches
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Testosterone Replacement Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Endo International
2.2.1 Business Overview
2.2.2 Testosterone Replacement Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Endo International Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eli lilly
2.3.1 Business Overview
2.3.2 Testosterone Replacement Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli lilly Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Testosterone Replacement Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Actavis (Allergan)
2.5.1 Business Overview
2.5.2 Testosterone Replacement Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Testosterone Replacement Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Testosterone Replacement Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teva
2.8.1 Business Overview
2.8.2 Testosterone Replacement Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Mylan
2.9.1 Business Overview
2.9.2 Testosterone Replacement Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Mylan Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Upsher-Smith
2.10.1 Business Overview
2.10.2 Testosterone Replacement Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Ferring Pharmaceuticals
2.11.1 Business Overview
2.11.2 Testosterone Replacement Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Kyowa Kirin
2.12.1 Business Overview
2.12.2 Testosterone Replacement Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Acerus Pharmaceuticals
2.13.1 Business Overview
2.13.2 Testosterone Replacement Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Testosterone Replacement Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Testosterone Replacement Therapy Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Testosterone Replacement Therapy Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Testosterone Replacement Therapy Manufacturer Market Share in 2018
3.3.2 Top 6 Testosterone Replacement Therapy Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Testosterone Replacement Therapy Market Analysis by Regions
4.1 Global Testosterone Replacement Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Testosterone Replacement Therapy Sales and Market Share by Regions (2014-2019)
4.1.2 Global Testosterone Replacement Therapy Revenue and Market Share by Regions (2014-2019)
4.2 North America Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
4.3 Europe Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
4.5 South America Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
5 North America Testosterone Replacement Therapy by Country
5.1 North America Testosterone Replacement Therapy Sales, Revenue and Market Share by Country
5.1.1 North America Testosterone Replacement Therapy Sales and Market Share by Country (2014-2019)
5.1.2 North America Testosterone Replacement Therapy Revenue and Market Share by Country (2014-2019)
5.2 United States Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
5.3 Canada Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
5.4 Mexico Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
6 Europe Testosterone Replacement Therapy by Country
6.1 Europe Testosterone Replacement Therapy Sales, Revenue and Market Share by Country
6.1.1 Europe Testosterone Replacement Therapy Sales and Market Share by Country (2014-2019)
6.1.2 Europe Testosterone Replacement Therapy Revenue and Market Share by Country (2014-2019)
6.2 Germany Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
6.3 UK Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
6.4 France Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
6.5 Russia Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
6.6 Italy Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
7 Asia-Pacific Testosterone Replacement Therapy by Country
7.1 Asia-Pacific Testosterone Replacement Therapy Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Testosterone Replacement Therapy Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Testosterone Replacement Therapy Revenue and Market Share by Country (2014-2019)
7.2 China Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
7.3 Japan Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
7.4 Korea Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
7.5 India Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
8 South America Testosterone Replacement Therapy by Country
8.1 South America Testosterone Replacement Therapy Sales, Revenue and Market Share by Country
8.1.1 South America Testosterone Replacement Therapy Sales and Market Share by Country (2014-2019)
8.1.2 South America Testosterone Replacement Therapy Revenue and Market Share by Country (2014-2019)
8.2 Brazil Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
8.3 Argentina Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
8.4 Colombia Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
9 Middle East and Africa Testosterone Replacement Therapy by Countries
9.1 Middle East and Africa Testosterone Replacement Therapy Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Testosterone Replacement Therapy Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Testosterone Replacement Therapy Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
9.3 Turkey Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
9.4 Egypt Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
9.5 Nigeria Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
9.6 South Africa Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)
10 Global Testosterone Replacement Therapy Market Segment by Type
10.1 Global Testosterone Replacement Therapy Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Testosterone Replacement Therapy Sales and Market Share by Type (2014-2019)
10.1.2 Global Testosterone Replacement Therapy Revenue and Market Share by Type (2014-2019)
10.2 Gels Sales Growth and Price
10.2.1 Global Gels Sales Growth (2014-2019)
10.2.2 Global Gels Price (2014-2019)
10.3 Injections Sales Growth and Price
10.3.1 Global Injections Sales Growth (2014-2019)
10.3.2 Global Injections Price (2014-2019)
10.4 Patches Sales Growth and Price
10.4.1 Global Patches Sales Growth (2014-2019)
10.4.2 Global Patches Price (2014-2019)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2014-2019)
10.5.2 Global Other Price (2014-2019)
11 Global Testosterone Replacement Therapy Market Segment by Application
11.1 Global Testosterone Replacement Therapy Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Testosterone Replacement Therapy Market Forecast (2019-2024)
12.1 Global Testosterone Replacement Therapy Sales, Revenue and Growth Rate (2019-2024)
12.2 Testosterone Replacement Therapy Market Forecast by Regions (2019-2024)
12.2.1 North America Testosterone Replacement Therapy Market Forecast (2019-2024)
12.2.2 Europe Testosterone Replacement Therapy Market Forecast (2019-2024)
12.2.3 Asia-Pacific Testosterone Replacement Therapy Market Forecast (2019-2024)
12.2.4 South America Testosterone Replacement Therapy Market Forecast (2019-2024)
12.2.5 Middle East and Africa Testosterone Replacement Therapy Market Forecast (2019-2024)
12.3 Testosterone Replacement Therapy Market Forecast by Type (2019-2024)
12.3.1 Global Testosterone Replacement Therapy Sales Forecast by Type (2019-2024)
12.3.2 Global Testosterone Replacement Therapy Market Share Forecast by Type (2019-2024)
12.4 Testosterone Replacement Therapy Market Forecast by Application (2019-2024)
12.4.1 Global Testosterone Replacement Therapy Sales Forecast by Application (2019-2024)
12.4.2 Global Testosterone Replacement Therapy Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Testosterone Replacement Therapy Picture
Table Product Specifications of Testosterone Replacement Therapy
Figure Global Sales Market Share of Testosterone Replacemen
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
